Table 1.
Baseline Patient and Provider Characteristics
| Total Sample | Intervention | Control | Control vs. Intervention p-value | |
|---|---|---|---|---|
| Provider Characteristics | N=26 | n=13 | n=13 | |
|
| ||||
| Age, Mean (SD) | 46 (9) | 46 (10) | 46 (9) | 0.902 |
| Female, n(%) | 12 (48) | 5 (38) | 8 (66) | 0.158 |
| White, n(%) | 17 (71) | 9 (75) | 8 (66) | 0.653 |
|
| ||||
| Patient Characteristics | N=160 | n=81 | n=79 | |
|
| ||||
| Age, Mean (SD) | 45.1 (8.4) | 45.4 (8.2) | 44.9 (8.6) | 0.711 |
| Female, n(%) | 51 (33) | 28 (36) | 23 (29) | 0.393 |
| High school degree, n (%) | 112 (72) | 53 (67) | 59 (77) | 0.228 |
| Race/Ethnicity | ||||
| Non-Hispanic Black, n(%) | 78 (50) | 37 (47) | 41 (53) | |
| Non-Hispanic White, n(%) | 53 (34) | 25 (32) | 28 (36) | |
| Hispanic, n(%) | 17 (11) | 11 (14) | 6 (8) | 0.504 |
| Active drug use, n(%) | 60 (38) | 38 (35) | 32 (41) | 0.438 |
| On ARV, n(%) | 125 (78) | 62 (77) | 63 (80) | 0.624 |
| Adherence, n(%) reported “excellent” | 55 (37) | 28 (38) | 27 (36) | 0.905 |
| HIV RNA suppression (if on ARV), n (%) | 39 (25) | 16 (21) | 23 (31) | 0.150 |